
About Abia Pharmaceuticals Private Limited
Data last updated:
Abia Pharmaceuticals Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 29 December 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24233TN2011PTC083806. Its GSTIN is 06AAKCA2085Q1Z6 (Haryana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sunil Arora and Gopinath Raju.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 22/15 A Shanthi Nagar 2nd Street M. H. Road Perambur, Chennai, Tamil Nadu, India – 600011.
As per the financials filed for FY 2024, the company reported a revenue of ₹73.13 Lakh, a decline of 70% compared to the previous year. For the same year it recorded a net loss of ₹6.66 Lakh (net margin -9.1%) and EBITDA of -₹4.06 Lakh (EBITDA margin -5.6%). Revenue has declined at a compounded annual rate (CAGR) of 34% over three years and 25% over five years.
As per MCA filings, the company has open charges of ₹11.5 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website abiaindia.com.
Company details
Contact details
Abia Pharmaceuticals Private Limited's registered office is in Chennai, Tamil Nadu. Its website is abiaindia.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address22/15 A Shanthi Nagar 2nd Street M. H. Road Perambur, Chennai, Tamil Nadu, India – 600011
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Abia Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Abia Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Abia Pharmaceuticals Private Limited, buy the company report.
Financials of Abia Pharmaceuticals Private Limited
FY 2025 filings availableAbia Pharmaceuticals Private Limited reported revenue of ₹73.13 Lakh (down 70% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 25% over five years, including a 70% fall in the latest year. EBITDA fell 150% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹4.06 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹6.66 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -5.6% | ||||
| Net Profit Margin | -9.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Abia Pharmaceuticals Private Limited, buy the company report.
Board of directors of Abia Pharmaceuticals Private Limited
Abia Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sunil Arora | Director | 29 Dec 2011 | 14 Years 10 Months | Current |
| Gopinath Raju | Director | 29 Dec 2011 | 14 Years 10 Months | Current |
Peer comparison
Abia Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ambromide Pharma Private Limited | ₹73.21 Lakh (FY 2025) | -41.0% | Manimajra, Chandigarh, India | |||
| N Lexo Pharma Private Limited | ₹73.19 Lakh (FY 2024) | 383.0% | Gandhinagar, Gujarat, India | |||
| Asteroids Pharmaceutical Private Limited | ₹73.17 Lakh (FY 2025) | 36.0% | Indore, Madhya Pradesh, India | |||
| Abia Pharmaceuticals Private Limitedthis company | ₹73.13 Lakh (FY 2024) | -₹6.66 Lakh | -9.1% | -70.0% | Chennai, Tamil Nadu, India | |
| Pci Bioscience Private Limited | ₹73.08 Lakh (FY 2024) | -14.0% | Mandi Adampur, Haryana, India | |||
| Tirupati Pharmaceuticals Private Limited | ₹73.07 Lakh (FY 2021) | -30.0% | New Delhi, Delhi, India | |||
| Caraway Pharma Private Limited | ₹72.97 Lakh (FY 2021) | -54.0% | Madurai, Tamil Nadu, India |
To see the full peer comparison of Abia Pharmaceuticals Private Limited, buy the company report.
Auditor
Abia Pharmaceuticals Private Limited is audited by YOGITABAWEJA for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| YOGITABAWEJA | FY 2022 | 538445 |
Shareholding
The shareholding of Abia Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Abia Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 17 Aug 2021 | 100490434 | Hdfc Bank Limited | ₹11.5 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Abia Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Abia Pharmaceuticals Private Limited has 6 MSME Form 1 returns on record between 2017 and 2022, listing 67 overdue payments to 23 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 23)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| G Nine Bioceuticals Private Limited | |||
| an individual supplier | |||
| Altar Health Care Private Limited | |||
| an individual supplier |
To see the full MSME payment records of Abia Pharmaceuticals Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Abia Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAKCA2085Q1Z6 | Haryana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Abia Pharmaceuticals Private Limited, buy the company report.
Recent activity
Abia Pharmaceuticals Private Limited has 6 board changes on record since 2011: 4 appointments and 2 cessations. The latest: Murugan Chellappa ceased to be Director on 28 Nov 2014.
Frequently asked questions
Abia Pharmaceuticals is an active private limited company based in Chennai, Tamil Nadu, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 29 December 2011 (15+ years old) and is registered under CIN U24233TN2011PTC083806.
Abia Pharmaceuticals has 2 current directors:
- Sunil Arora - Director
- Gopinath Raju - Director
The latest financial statements of Abia Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Abia Pharmaceuticals is 06AAKCA2085Q1Z6, registered in Haryana.
The CIN (Corporate Identification Number) of Abia Pharmaceuticals is U24233TN2011PTC083806. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Abia Pharmaceuticals was incorporated on 29 December 2011, making it 15+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Abia Pharmaceuticals by revenue are Ambromide Pharma Private Limited, N Lexo Pharma Private Limited, Asteroids Pharmaceutical Private Limited, Pci Bioscience Private Limited, Tirupati Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Murugan Chellappa ceased to be Director on 28 Nov 2014. Rajan Sundhara Krishnan ceased to be Director on 28 Nov 2014. Gopinath Raju was appointed as Director on 29 Dec 2011. Abia Pharmaceuticals has 6 board changes on record in total.
Abia Pharmaceuticals has 6 MSME Form 1 returns on record between 2017 and 2022, listing 67 overdue payments to 23 micro and small suppliers. The latest return was filed on 30 Apr 2022.
Abia Pharmaceuticals can be reached through the website abiaindia.com. Its registered office is in Chennai, Tamil Nadu, India.
The registered office of Abia Pharmaceuticals is at 2215 A Shanthi Nagar 2nd Street M. H. Road Perambur, Chennai, Tamil Nadu, India – 600011.
Abia Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

